|

Low-Dose Total Skin Electron Therapy in Treating Patients With Refractory or Relapsed Stage IB-IIIA Mycosis Fungoides

RECRUITINGSponsored by Vanderbilt-Ingram Cancer Center
Actively Recruiting
SponsorVanderbilt-Ingram Cancer Center
Started2016-05-22
Est. completion2026-09
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT02702310

Summary

This clinical trial studies low- dose total skin electron therapy in treating patients with stage IB-IIIA mycosis fungoides that has not responded to previous treatment (refractory) or has returned after a period of improvement (relapsed). Radiation therapy uses high energy electrons to kill tumor cells and shrink tumors. Rotisserie technique is a method in which the patient receives total skin electron therapy while standing on a rotating platform. Giving low dose total skin electron therapy using rotisserie technique may kill tumor cells, while having fewer side effects, and may allow therapy to be repeated in future if clinically indicated.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Biopsy confirmed mycosis fungoides stage IB-IIIA
* Skin manifestations of mycosis fungoides that are refractory to or have relapsed on at least one prior therapy, which may include topical steroids
* Life expectancy \> 6 months

Exclusion Criteria:

* Serious medical condition that would make treatment unsafe
* Pregnant or lactating patient

Conditions6

CancerRecurrent Mycosis FungoidesRefractory Mycosis FungoidesStage I Mycosis FungoidesStage II Mycosis FungoidesStage III Mycosis Fungoides

Locations1 site

Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, 37232
Austin Kirschner, MD, PhD

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.